2008 Research Symposium
Guest Speaker J. Lyle Bootman PhD
|
|
Dr. Bootman is Dean of The University of Arizona
College of Pharmacy. He is professor of
pharmacy, medicine and public health, and a Fellow
of several professional associations including the
American Pharmacists Association, American
Association of Pharmaceutical Scientists and the
American College of Apothecaries. He is the
founding and executive director of The University
of Arizona Center for Health Outcomes and
PharmacoEconomic (HOPE) Research, one of the first
such centers developed in the world. He is former
president of |
the American Pharmacists Association and President Emeritus of the Pharmacy & Therapeutics Society.
He received his pharmacy education at The University of
Arizona and his doctorate at The University of Minnesota
where he was given the Outstanding Achievement
Award,” the University’s highest Alumni
honor. He completed a clinical pharmacy residency
at the world-renowned National Institutes of Health, and
received an honorary doctorate from the University of the
Sciences in Philadelphia, the first such institution
founded in the
United States in 1821.
Dr. Bootman has authored over 275 research articles, books and monographs, and has been an invited speaker at more than 500 professional healthcare meetings and symposia. He was selected as one of the 50 most influential pharmacists in the U.S. by American Druggist, and has received numerous outstanding scientific achievement awards, most notably from the American Association of Pharmaceutical Scientists and the Academy of Pharmaceutical Science and Research for his research which pioneered the field of pharmacoeconomics and health outcomes. He has published several books including the first text introducing the Principles of Pharmacoeconomics, which is utilized in more than 35 countries and translated in seven languages. His research regarding the outcomes of drug-related morbidity and mortality receives worldwide attention by the professional and the public media.
Additionally, he is an elected member of the Institute of Medicine (IOM) of the National Academies, where he currently serves on the Board of Health Care Services, and Co-Chair of the IOM Committee which released the highly publicized report, “Preventing Medication Errors.” He serves as an advisor to leading pharmaceutical companies, universities and health care organizations throughout the world. Currently, he serves on the boards of The Critical Path Institute and Research Corporation Technologies. He was the recipient of the George Archambault Award, the highest honor given by the American Society of Consultant Pharmacists and the Latiolais Honor Medal, the highest honor in managed health care. Additionally, he was the recipient the Award of Excellence given by the American Society of Health Systems Pharmacists, and the Hugo H. Schaefer Award which recognizes outstanding lifetime contributions to the organization, the profession and to society, given by the American Pharmacists Association.
It was recently announced that he will be receiving the
Joseph P. Remington Honor Medal, the highest honor given
by the profession of pharmacy to recognize distinguished
service and for lifetime contributions.